162 related articles for article (PubMed ID: 36403136)
1. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: Based on a Japanese nationwide study.
Kubota K; Kamisawa T; Nakazawa T; Tanaka A; Naitoh I; Kurita Y; Takikawa H; Unno M; Kawa S; Masamune A; Nakamura S; Okazaki K;
J Gastroenterol Hepatol; 2023 Apr; 38(4):556-564. PubMed ID: 36403136
[TBL] [Abstract][Full Text] [Related]
2. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
[TBL] [Abstract][Full Text] [Related]
3. IgG4-related sclerosing cholangitis may be a risk factor for cancer.
Kurita Y; Fujita Y; Sekino Y; Watanabe S; Iwasaki A; Kagawa K; Tanida E; Yagi S; Hasegawa S; Sato T; Hosono K; Kato S; Kobayashi N; Ichikawa Y; Endo I; Nakajima A; Kubota K
J Hepatobiliary Pancreat Sci; 2021 Jun; 28(6):524-532. PubMed ID: 33931982
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort.
Naitoh I; Kamisawa T; Tanaka A; Nakazawa T; Kubota K; Takikawa H; Unno M; Masamune A; Kawa S; Nakamura S; Okazaki K;
Dig Liver Dis; 2021 Oct; 53(10):1308-1314. PubMed ID: 33664004
[TBL] [Abstract][Full Text] [Related]
5. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
[No Abstract] [Full Text] [Related]
6. Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.
Martínez-Valle F; Riveiro-Barciela M; Salcedo MT; Merino-Casabiel X; Fernández-Codina A; Torres I; Esteban R; Buti M
Ann Hepatol; 2019; 18(1):215-219. PubMed ID: 31113593
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: A multicenter cohort study.
Cho SH; Song TJ; Park JS; Yoon JH; Yang MJ; Yoon SB; Lee JM; Lee YN; Kim SH; Choi EK; Park SW; Oh D; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
J Gastroenterol Hepatol; 2023 Apr; 38(4):648-655. PubMed ID: 36710432
[TBL] [Abstract][Full Text] [Related]
8. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
[TBL] [Abstract][Full Text] [Related]
9. IgG4-related sclerosing cholangitis- A great mimicker.
Nayak HK; Bhat SJ; Panigrahi MK; Chouhan I; Kumar C; Samal SC
Indian J Gastroenterol; 2020 Dec; 39(6):614-618. PubMed ID: 33156480
[TBL] [Abstract][Full Text] [Related]
10. [Paying attention to the diagnosis and treatment of IgG4-related sclerosing cholangitis].
Li BL; Xiao JC
Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):508-512. PubMed ID: 31269612
[TBL] [Abstract][Full Text] [Related]
11. Advances in IgG4-related pancreatobiliary diseases.
Kamisawa T; Zen Y; Nakazawa T; Okazaki K
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):575-585. PubMed ID: 30047448
[TBL] [Abstract][Full Text] [Related]
12. IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: A multicenter cohort study.
Kurita Y; Kubota K; Fujita Y; Tsujino S; Sekino Y; Kasuga N; Iwasaki A; Iwase M; Izuka T; Kagawa K; Tanida E; Yagi S; Hasegawa S; Sato T; Hosono K; Kobayashi N; Ichikawa Y; Nakajima A; Endo I
J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):173-182. PubMed ID: 38124014
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Pancreatitis and Immunoglobulin G4-related Sclerosing Cholangitis: Past, Present, and Future.
Moon SH; Kim MH
Korean J Gastroenterol; 2022 Sep; 80(3):107-114. PubMed ID: 36156034
[TBL] [Abstract][Full Text] [Related]
14. First case of IgG4-related sclerosing cholangitis associated with autoimmune hemolytic anemia.
Masutani H; Okuwaki K; Kida M; Yamauchi H; Imaizumi H; Miyazawa S; Iwai T; Takezawa M; Koizumi W
World J Gastroenterol; 2014 Jul; 20(26):8740-4. PubMed ID: 25024635
[TBL] [Abstract][Full Text] [Related]
15. [Recent Updates of Immunoglobulin G4-related Pancreatobiliary Disease].
Lee GC; Moon SH
Korean J Gastroenterol; 2020 May; 75(5):257-263. PubMed ID: 32448857
[TBL] [Abstract][Full Text] [Related]
16. Relapse patterns and predictors of IgG4-related diseases involved with autoimmune pancreatitis: A single-center retrospective study of 115 patients.
Miki M; Fujimori N; Oono T; Kawabe K; Ohno A; Matsumoto K; Teramatsu K; Tachibana Y; Ogawa Y
J Dig Dis; 2019 Mar; 20(3):152-158. PubMed ID: 30701685
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis.
Lanzillotta M; Della-Torre E; Wallace ZS; Stone JH; Karadag O; Fernández-Codina A; Arcidiacono PG; Falconi M; Dagna L; Capurso G
Pancreatology; 2021 Oct; 21(7):1395-1401. PubMed ID: 34244040
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G4-related pancreatic and biliary diseases.
Al-Dhahab H; McNabb-Baltar J; Al-Busafi S; Barkun AN
Can J Gastroenterol; 2013 Sep; 27(9):523-30. PubMed ID: 24078937
[TBL] [Abstract][Full Text] [Related]
19. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Tanaka A
Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
[TBL] [Abstract][Full Text] [Related]
20. A case report of immunoglobulin G4-related sclerosing cholangitis with multiple relapse.
Dong X; Huo N; Wu Z; Wang G; Wang H; Zhao H
Medicine (Baltimore); 2018 May; 97(19):e0700. PubMed ID: 29742724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
